TRAJECTORIES OF ANASTROZOLE ADHERENCE AND NEUROPSYCHOLOGICAL SYMPTOM BURDEN IN POSTMENOPAUSAL WOMEN WITH EARLY-STAGE BREAST CANCER 18-MONTHS POST-INITIATION OF AROMATASE INHIBITOR THERAPY

被引：0
|
作者：
McCall, Maura [1 ]
Rosenzweig, Margaret Quinn [2 ]
Conley, Yvette [2 ]
Beumer, Jan [2 ]
Sereika, Susan [3 ]
Bender, Catherine [3 ]
机构：
[1] Case Western Reserve Univ, Cleveland, OH USA
[2] Univ Pittsburgh, Pittsburgh, PA USA
[3] Univ Pittsburgh, Sch Nursing, Pittsburgh, PA USA
来源：
ONCOLOGY NURSING FORUM | 2023年 / 50卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Periodontal Health in Women With Early-Stage Postmenopausal Breast Cancer Newly on Aromatase Inhibitors: A Pilot Study
    Taichman, L. Susan
    Inglehart, Marita R.
    Giannobile, William V.
    Braun, Thomas
    Kolenic, Giselle
    Van Poznak, Catherine
    JOURNAL OF PERIODONTOLOGY, 2015, 86 (07) : 906 - 916
  • [32] A cost-effectiveness analysis of adjuvant therapy with exemestane, anastrozole, letrozole or tamoxifen in postmenopausal women with early-stage breast cancer in Mexico
    Mould-Quevedo, J.
    Tapia-Valencia, J.
    Davila-Loaiza, G.
    VALUE IN HEALTH, 2007, 10 (03) : A124 - A125
  • [33] Prevention of aromatase inhibitor-induced bone loss with anti-resorptive therapy in post-menopausal women with early-stage breast cancer
    Mugnier, Benedicte
    Goncalves, Anthony
    Daumas, Aurelie
    Couderc, Anne-Laure
    Mezni, Essia
    Viret, Frederic
    de Nonneville, Alexandre
    Villani, Patrick
    OSTEOPOROSIS INTERNATIONAL, 2023, 34 (04) : 703 - 711
  • [34] Acupuncture for the Management of Aromatase Inhibitor-Associated Joint Symptoms in Women with Early-Stage Breast Cancer
    Stranzl, Heidi
    STRAHLENTHERAPIE UND ONKOLOGIE, 2010, 186 (10) : 584 - 585
  • [35] Molecular and clinical effects of aromatase inhibitor therapy on skeletal muscle function in early-stage breast cancer
    Seibert, Tara A.
    Shi, Lei
    Althouse, Sandra
    Hoffman, Richard
    Schneider, Bryan P.
    Russ, Kristen A.
    Altherr, Cody A.
    Warden, Stuart J.
    Guise, Theresa A.
    Coggan, Andrew R.
    Ballinger, Tarah J.
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [36] Effect of combination therapy of eldecalcitol and risedronate on aromatase inhibitor induced bone loss in postmenopausal women with early-stage breast cancer: an open-label randomized trial
    Imanishi, Yasuo
    Imai, Takumi
    Fujii, Hisako
    Aida, Rei
    Nagata, Yuki
    Shoji, Tetsuo
    Kashiwagi, Shinichiro
    Takashima, Tsutomu
    Emoto, Masanori
    JOURNAL OF BONE AND MINERAL RESEARCH, 2023, 38 : 358 - 359
  • [37] AROMATASE INHIBITOR- INDUCED CHANGES IN THE LIPID PROFILE OF POSTMENOPAUSAL WOMEN WITH EARLY STAGE BREAST CANCER.
    Bell, L. N.
    Nguyen, A. T.
    Li, L.
    Desta, Z.
    Flockhart, D. A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 : S79 - S79
  • [38] Does adjuvant therapy with letrozole improve survival in postmenopausal women with early-stage breast cancer?
    Lonning, Per E.
    Geisler, Juergen
    NATURE CLINICAL PRACTICE ONCOLOGY, 2006, 3 (07): : 356 - 357
  • [39] Does adjuvant therapy with letrozole improve survival in postmenopausal women with early-stage breast cancer?
    Per E Lønning
    Jürgen Geisler
    Nature Clinical Practice Oncology, 2006, 3 : 356 - 357
  • [40] Optimizing adjuvant endocrine therapy in postmenopausal women with early-stage breast cancer: A decision analysis
    Punglia, RS
    Kuntz, KM
    Winer, EP
    Weeks, JC
    Burstein, HJ
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (22) : 5178 - 5187
12345